ChemicalBook >> CAS DataBase List >>1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- structure

CAS No.: 95716-67-9

Chemical Name:: 1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-

Synonyms: Paricalcitol-3;Paricalcitol Impurity 5;Paricalcitol Impurity A01;(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol;(1R,3aR,4S,7aR)-1-((2R,5S,E)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol;(1R,3aR,4S,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-ol;<1R<1β(R*,E,S*),3aα,4β,7aβ>>-6-(Octahydro-4-hydroxy-7a-methyl-1H-inden-1-yl)-2,3-dimethyl-4-hepten-2-ol;1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-;(1R,3aR,4S,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-ol;Paricalcitol impurity 3/(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol

CBNumber:: CB42667928

Molecular Formula:: C19H34O2

Molecular Weight:: 294.47

MDL Number:

MOL File:: 95716-67-9.mol

Last updated:2023-04-27 16:27:43

Request For Quotation

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Properties

Boiling point	402.8±18.0 °C(Predicted)
Density	0.997±0.06 g/cm3(Predicted)
pka	14.93±0.29(Predicted)

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Chemical Properties,Uses,Production

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- synthesis

Synthesis of 1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- from (2S)-2-((1R,3aR,7aR)-4-(tert-butyldiMethylsilyloxy)-7a-Methyloctahydro-1H-inden-1-yl)propanal

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Preparation Products And Raw materials

Raw materials

(2S)-2-((1R,3aR,7aR)-4-(tert-butyldiMethylsilyloxy)-7a-Methyloctahydro-1H-inden-1-yl)propanal

Preparation Products

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Suppliers

Global( 32)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14336	58
CR Corporation Lomited		fred.wen@crcorporation.cn	CHINA	12069	58
Hangzhou Huarong Pharm Co., Ltd.	571-86758373 +8613588754946	sales@huarongpharm.com	CHINA	3149	58
Wuhan Topule Biopharmaceutical Co., Ltd	+8618327326525	masar@topule.com	China	8474	58
Shanghai Payne Pharmaceutical Technology Co.Ltd	021-58123769 18678586262	info@paynepharm.com	China	1354	58
Beijing Comparison Pharmaceutical Technology Co., Ltd	010-52878169 15701683040	sales@bjcomparison.com	China	4681	58
Wuxi Zhongkun Biochemical Technology Co., Ltd.	0510-85629785 18013409632	sales@reading-chemicals.com	China	15185	58
Gansu HaoTian Chemical Technology Co., Ltd.	0943-6900332 17789447501	zhuanxiajiang@haotianpharm.com	China	209	55
Zhengzhou Kangshan Biological Co., Ltd.	+86-0371-55023472 +86-13663848272	2584787837@qq.com	China	167	58
Anhui Feixiang Pharmaceutical Technology Co., Ltd.	13349001619	sales@feixiangpharm.com	China	1008	58

Supplier	Advantage
Standardpharm Co. Ltd.	58
CR Corporation Lomited	58
Hangzhou Huarong Pharm Co., Ltd.	58
Wuhan Topule Biopharmaceutical Co., Ltd	58
Shanghai Payne Pharmaceutical Technology Co.Ltd	58
Beijing Comparison Pharmaceutical Technology Co., Ltd	58
Wuxi Zhongkun Biochemical Technology Co., Ltd.	58
Gansu HaoTian Chemical Technology Co., Ltd.	55
Zhengzhou Kangshan Biological Co., Ltd.	58
Anhui Feixiang Pharmaceutical Technology Co., Ltd.	58

95716-67-9(1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-)Related Search:

2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol 2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol PL-A':(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one PL-AS':(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimeth ylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one benzyl (4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl) carbamate 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine

(3S,6R,E)-6-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis ((tert-butyldimethylsilyl)oxy)cyclohexylidene) ethylidene)-7a-methyloctahydro-1H-inden-1-yl)- 2,3-dimethylhept-4-en-2-ol (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy- 5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H- inden-4-ylidene)ethylidene)cyclohexane-1,3-diol tert-butyl(((1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl -6-((tetrahydro-2H-pyran-2-yl)oxy)hept-3-en-2-yl) -7a-methyloctahydro-1H-inden-4-yl)oxy)dimethylsilane (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((trimethylsilyl)oxy)hept-3-en-2-yl)-7a- methyloctahydro-4H-inden-4-one (1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one

(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one

1of3

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- (1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol (1R,3aR,4S,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-ol Paricalcitol Impurity 5 (1R,3aR,4S,7aR)-1-((2R,5S,E)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol Paricalcitol-3 Paricalcitol impurity 3/(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol <1R<1β(R*,E,S*),3aα,4β,7aβ>>-6-(Octahydro-4-hydroxy-7a-methyl-1H-inden-1-yl)-2,3-dimethyl-4-hepten-2-ol (1R,3aR,4S,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-ol Paricalcitol Impurity A01 95716-67-9